Your browser doesn't support javascript.
loading
Adalimumab and infliximab survival in patients with hidradenitis suppurativa: a daily practice cohort study.
Prens, L M; Bouwman, K; Aarts, P; Arends, S; van Straalen, K R; Dudink, K; Horváth, B; Prens, E P.
Afiliación
  • Prens LM; Department of Dermatology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
  • Bouwman K; Department of Dermatology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
  • Aarts P; Erasmus MC, University Medical Center Rotterdam, Department of Dermatology, Rotterdam, the Netherlands.
  • Arends S; Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, Groningen, the Netherlands.
  • van Straalen KR; Erasmus MC, University Medical Center Rotterdam, Department of Dermatology, Rotterdam, the Netherlands.
  • Dudink K; Erasmus MC, University Medical Center Rotterdam, Department of Dermatology, Rotterdam, the Netherlands.
  • Horváth B; Department of Dermatology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
  • Prens EP; Erasmus MC, University Medical Center Rotterdam, Department of Dermatology, Rotterdam, the Netherlands.
Br J Dermatol ; 185(1): 177-184, 2021 07.
Article en En | MEDLINE | ID: mdl-33544917
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Hidradenitis Supurativa Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Humans País/Región como asunto: Europa Idioma: En Revista: Br J Dermatol Año: 2021 Tipo del documento: Article País de afiliación: Países Bajos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Hidradenitis Supurativa Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Humans País/Región como asunto: Europa Idioma: En Revista: Br J Dermatol Año: 2021 Tipo del documento: Article País de afiliación: Países Bajos